Skip to content

Clinical trials

Observational Acute Coronary Syndrome trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Acute Coronary Syndrome Phase: Observational Clear all

585 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20022
20033
20041
20057
200615
200713
200812
200915
201028
201129
201218
201328
201430
201533
201628
201738
201844
201939
202024
202136
202229
202323
202434
202524
202625

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed298
Unknown status149
Recruiting67
Not yet recruiting28
Active, not recruiting17
Terminated14
Withdrawn6
Enrolling by invitation4
Suspended2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca24
Assiut University13
Sohag University10
Seoul National University Hospital9
Assistance Publique - Hôpitaux de Paris8
Federico II University6
Wake Forest University Health Sciences6
A.O.U. Città della Salute e della Scienza5
Bayer5
Beijing Anzhen Hospital5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Acute Coronary Syndrome585
Myocardial Infarction111
Coronary Artery Disease84
Chest Pain50
Angina, Unstable45
Non-ST Elevated Myocardial Infarction44
ST Elevation Myocardial Infarction42
Cardiovascular Diseases37
Myocardial Ischemia31
Heart Failure25

Trials

Showing 1 to 25 of 585. Each trial links to its page on Pharma Observatory.

485 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.